BAKER BROS. ADVISORS LP Insider Trades

Insider Trading History

Track insider trading activity for BAKER BROS. ADVISORS LP. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Incyte
Incyte INCY
10% owner
Holding Value $3.25B 28,205,760 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90.7k 800 shares
$113.36
$115.09
Kodiak Sciences
Kodiak Sciences KOD
10% owner
Holding Value $752k 17,731 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$691k 17,731 shares
$38.96
$42.42
vTv Therapeutics
vTv Therapeutics VTVT
Director
Holding Value $191k 6,000 shares
Last Trade
Jun 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$210k 6,000 shares
$35.08
$31.88
Kymera Therapeutics
Kymera Therapeutics KYMR
10% owner
Holding Value $692k 6,068 shares
Last Trade
Jun 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$606k 6,068 shares
$99.87
$114.12
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Director
Holding Value $1.07B 1,948,876 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.67M 3,348 shares
$499.76
$550.25
Prelude Therapeutics
Prelude Therapeutics PRLD
10% owner
Holding Value $169k 38,000 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 38,000 shares
$3.94
$4.46
Incyte
Incyte INCY
10% owner
Holding Value $3.25B 28,205,360 shares
Last Trade
Jun 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$946k 9,395 shares
$100.64
$115.09
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $78.8M 3,422,366 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.01M 51,268 shares
$19.66
$23.02
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
Director
Holding Value $169M 2,744,894 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.35M 48,630 shares
$48.38
$61.69
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
10% owner
Holding Value $1.02B 39,384,587 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.5M 69,252 shares
$21.66
$25.92
Tscan Therapeutics
Tscan Therapeutics TCRX
Director
Holding Value $62.3k 67,000 shares
Last Trade
May 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66.3k 67,000 shares
$0.99
$0.93
Incyte
Incyte INCY
10% owner
Holding Value $0 0 shares
Last Trade
May 08, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.48M 15,000 shares
$98.56
$115.09
Incyte
Incyte INCY
10% owner
Holding Value $3.25B 28,203,718 shares
Last Trade
May 08, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.48M 15,000 shares
$98.56
$115.09
Incyte
Incyte INCY
10% owner
Holding Value $326M 2,833,039 shares
Last Trade
May 08, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.48M 15,000 shares
$98.56
$115.09
Prelude Therapeutics
Prelude Therapeutics PRLD
10% owner
Holding Value $7.49M 1,678,273 shares
Last Trade
Apr 21, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$529k 114,601 shares
$4.62
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
10% owner
Holding Value $89.7M 20,105,994 shares
Last Trade
Apr 21, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.88M 2,137,651 shares
$4.62
$4.46
Replimune Group
Replimune Group REPL
10% owner
Holding Value $431k 44,500 shares
Last Trade
Apr 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$339k 44,500 shares
$7.61
$9.68
Incyte
Incyte INCY
10% owner
Holding Value $324M 2,818,039 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.6k 421 shares
$94.12
$115.09
Incyte
Incyte INCY
10% owner
Holding Value $3.24B 28,188,718 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.6k 421 shares
$94.12
$115.09
DBV Technologies
DBV Technologies DBVT
Director
Holding Value $0 0 shares
Last Trade
Jan 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$448M 25,005,240 shares
$17.93
$15.71

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up